Photocure appoints Jane Healy as VP and general manager EMEA
Norwegian bladder cancer specialist Photocure (OSE: PHO) has appointed Jane Healy as vice president and general manager EMEA.
Ms Healy joined Photocure in March 2025 to lead the European organization. Her extensive international experience in the medical device field covers sales, marketing, general management and functional leadership. Over the past 30 years she has worked for three major medical device organizations; St Jude Medical, CR Bard and over 20 years for Boston Scientific.
In her most recent role, Ms Healy was VP EMEA for the Peripheral Interventions Division for Boston Scientific, responsible for driving the growth strategy for the region. She brings a blend of strong commercial acumen, results orientation and a passion for enabling and driving results through her teams.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze